News Centre

Robert Jaeger Joins TrackInsight As Vice President, Americas

Date 30/11/2020

• Adds significant firepower to TrackInsight's entreprise-level servicing during a period of explosive ETF growth
• Brings over 15 years of ETF experience including trading, portfolio management, research and strategy
• Senior hire supports TrackInsight's international growth via ETF-based data and technology solutions

S&P Global And IHS Markit To Merge In All-Stock Transaction Valuing IHS Markit At $44 Billion, Powering The Markets Of The Future

Date 30/11/2020

• Joins Two World-Class Organizations with Unique, Highly Complementary Assets to Enhance Customer Value Proposition
• Combined Company to Benefit from Increased Scale and Mix Across Core Markets with Attractive Growth Adjacencies
• Expected to be Accretive to Earnings by the End of the Second Full Year Post-Closing with ~$480 Million of Annual Run-Rate Cost Synergies and ~$350 Million of Revenue Synergies
• Pro Forma Company to Target Capital Return of at Least 85% of Free Cash Flow
• Companies to Host Conference Call Today at 8:15 a.m. ET / 1:15 p.m. GMT

HKEX: Report On Initial Public Offering Applications, Delisting And Suspensions

Date 30/11/2020

Report on Initial Public Offering Applications, Delisting and Suspensions (As at 30 November 2020)

Japan Exchange Group: Retirement Of Representative Executive Officer And Related Matters

Date 30/11/2020

Japan Exchange Group, Inc. (JPX) today announces that Miyahara Koichiro, Director & Representative Executive Officer, Group Co-COO of JPX, has taken seriously his responsibility for the failure in the arrowhead cash equity trading system that occurred on October 1, 2020, and has requested to resign from his position as President & CEO of Tokyo Stock Exchange, Inc. (TSE) and all other held positions within the Group, effective on November 30, 2020. JPX has accepted this request.

Acuiti: Investment In Derivatives Post-Trade Set To Soar - Experience During The Covid Volatility Has Accelerated Plans For The Sell-Side To Invest In Back-Office Operations

Date 30/11/2020

95% of tier 1 and 2 banks plan to invest more in derivatives post-trade operations over the next three years than in the last three, a major study by Acuiti has found.

Japan Exchange Group: Business Improvement Orders On System Failure And Clarification Of Locus Of Responsibility

Date 30/11/2020

We deeply apologize again for the inconvenience caused to investors and other market users due to the system failure on October 1, 2020.

HKEX To Introduce New Stock Futures Contracts And Option Classes

Date 30/11/2020

Hong Kong Exchanges and Clearing Limited (HKEX) is pleased to announce today (Monday) the launch of four new stock futures contracts and four new stock option classes on Monday, 7 December 2020.

FXCM And Capitalise.ai Partner To Offer Advanced Trading Automation Tools

Date 30/11/2020

Capitalise.ai, a trading automation platform, and FXCM Group, LLC (‘FXCM Group’ or FXCM’), a market leader in online foreign exchange (FX), CFD, and cryptocurrency trading, announced a strategic partnership that offers FXCM’s clients access to a ground-breaking automated trading experience.    

Dubai Financial Market Pays Tribute To The UAE Martyrs - Hassan Al Serkal: “The Courageous Sacrifices Of Martyrs Will Always Be Treasured In Hearts Of The UAE People”

Date 30/11/2020

Dubai Financial Market (DFM) hosted a special ceremony on Monday, 30 November 2020, on the occasion of the Martyrs Commemoration Day,as the nation offers tribute to the courageous martyrs of the United Arab Emirates. The ceremony was held with participation of employees of DFM and Dubai Islamic Economy Development Centre as well as brokers and investors.

Hong Kong's Securities And Futures Commission Commences Legal Proceedings Against New Ray Medicine International Holding Limited And Its Former Top Executives

Date 30/11/2020

The Securities and Futures Commission (SFC) has commenced legal proceedings in the Court of First Instance to seek disqualification orders against former chairman and executive director of New Ray Medicine International Holding Limited (New Ray), Mr Zhou Ling, and the company’s former chief executive officer and executive director, Mr Dai Haidong, for allegedly committing corporate misconduct and breaching their duties towards New Ray.